Suppr超能文献

Charcot-Marie-Tooth 病、精神指标和生活质量:系统评价。

Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.

机构信息

*Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

出版信息

ASN Neuro. 2014 May 27;6(3):185-92. doi: 10.1042/AN20130048.

Abstract

This study is aimed to conduct a systematic literature review regarding the associations between psychiatric symptoms, functional impairments, and quality of life in patients with CMT (Charcot-Marie-Tooth). The PUBMED, PsycInfo, SCIELO, and LILACS electronic databases were used, and the following search terms were employed: CMT, HMSN (hereditary motor and sensory neuropathy), mental disorder, quality of life, psychiatry, psychiatric, and psychological without the use of time-limit filters. According to the adopted inclusion criteria, 20 studies were included and appraised. These studies indicated that patients with CMT exhibited an increased trend toward depressive symptoms compared with the general population. In addition, CMT patients were exposed to a higher risk of reduced quality of life and significant sleep impairment. Considering the comorbidity of CMT with other psychiatric disorders, the heterogeneity of the instruments used to evaluate the psychiatric symptoms compromised the ability to compare the studies examined. Our results indicate a need for a systematic evaluation of these conditions to minimize the impairments and decreased quality of life caused by CMT.

摘要

本研究旨在对 CMT(Charcot-Marie-Tooth)患者的精神症状、功能障碍和生活质量之间的关系进行系统文献回顾。使用了 PUBMED、PsycInfo、SCIELO 和 LILACS 电子数据库,并采用了以下搜索词:CMT、HMSN(遗传性运动感觉神经病)、精神障碍、生活质量、精神病学、精神病学和心理学,没有使用时间限制过滤器。根据采用的纳入标准,纳入并评估了 20 项研究。这些研究表明,与一般人群相比,CMT 患者表现出抑郁症状增加的趋势。此外,CMT 患者面临生活质量降低和严重睡眠障碍的风险更高。考虑到 CMT 与其他精神障碍的共病,用于评估精神症状的工具的异质性削弱了比较所检查研究的能力。我们的结果表明需要对这些情况进行系统评估,以最大限度地减少 CMT 引起的损伤和生活质量下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3885/4034707/cceac666898d/an2013-0048i001.jpg

相似文献

2
Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952.
3
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
J Neurol. 2017 Aug;264(8):1655-1677. doi: 10.1007/s00415-017-8474-3. Epub 2017 Mar 31.
4
Toxic medications in Charcot-Marie-Tooth patients: A systematic review.
J Peripher Nerv Syst. 2023 Sep;28(3):295-307. doi: 10.1111/jns.12566. Epub 2023 Jun 5.
5
Treatment for Charcot-Marie-Tooth disease.
Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD006052. doi: 10.1002/14651858.CD006052.pub2.
6
Rehabilitation interventions for foot drop in neuromuscular disease.
Cochrane Database Syst Rev. 2009 Jul 8(3):CD003908. doi: 10.1002/14651858.CD003908.pub3.
8
Gait in children and adolescents with Charcot-Marie-Tooth disease: a systematic review.
J Peripher Nerv Syst. 2016 Dec;21(4):317-328. doi: 10.1111/jns.12183.
9
Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.
J Peripher Nerv Syst. 2022 Jun;27(2):100-112. doi: 10.1111/jns.12489. Epub 2022 Apr 5.

引用本文的文献

1
Wellbeing measurement among adults with Charcot-Marie-Tooth disease.
Health Care Transit. 2024 Feb 28;2:100053. doi: 10.1016/j.hctj.2024.100053. eCollection 2024.
2
Expanding the genetic spectrum of hereditary motor sensory neuropathies in Pakistan.
BMC Neurol. 2024 Oct 16;24(1):394. doi: 10.1186/s12883-024-03882-y.
4
Playing Disability Rugby League with Charcot-Marie-Tooth Disease: A Case Study.
Sports (Basel). 2023 Jan 18;11(2):21. doi: 10.3390/sports11020021.
5
Genetic Spectrum of Inherited Neuropathies in India.
Ann Indian Acad Neurol. 2022 May-Jun;25(3):407-416. doi: 10.4103/aian.aian_269_22. Epub 2022 Jun 14.
6
Left to themselves: Time to target chronic pain in childhood rare diseases.
Neurosci Biobehav Rev. 2021 Jul;126:276-288. doi: 10.1016/j.neubiorev.2021.03.008. Epub 2021 Mar 24.
7
Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?
Front Psychiatry. 2019 Jan 9;9:739. doi: 10.3389/fpsyt.2018.00739. eCollection 2018.
8
Anesthetic Management of a Patient With Charcot-Marie-Tooth Disease.
Anesth Prog. 2016 Summer;63(2):80-3. doi: 10.2344/15-00010R1.1.

本文引用的文献

1
Sleep disorders in Charcot-Marie-Tooth disease type 1.
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):319-25. doi: 10.1136/jnnp-2013-305296. Epub 2013 May 23.
2
Health-related quality of life and supportive care in patients with rare long-term neurological conditions.
Qual Life Res. 2013 Aug;22(6):1231-8. doi: 10.1007/s11136-012-0269-5. Epub 2012 Sep 23.
3
Charcot-Marie-Tooth disease and related genetic neuropathies.
Continuum (Minneap Minn). 2012 Feb;18(1):39-59. doi: 10.1212/01.CON.0000411567.34085.da.
4
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):706-10. doi: 10.1136/jnnp-2012-302451. Epub 2012 May 10.
5
Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
Neuromuscul Disord. 2011 Jun;21(6):428-32. doi: 10.1016/j.nmd.2011.03.008. Epub 2011 Apr 29.
6
Charcot-Marie-Tooth disease subtypes and genetic testing strategies.
Ann Neurol. 2011 Jan;69(1):22-33. doi: 10.1002/ana.22166.
7
Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey.
J Neurol. 2010 Apr;257(4):646-52. doi: 10.1007/s00415-009-5390-1. Epub 2009 Nov 24.
8
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
9
10
Is there a higher risk of restless legs syndrome in peripheral neuropathy?
Neurology. 2009 Mar 17;72(11):955-60. doi: 10.1212/01.wnl.0000336341.72621.db. Epub 2008 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验